The field of chemical biology applies chemical techniques to investigate and manipulate biological systems, understand their underlying mechanisms, and address critical challenges in biotechnology and human health. By bridging chemistry and biology, this field enables researchers to develop novel tools for probing cellular processes and uncovering new therapeutic strategies.
The Chemical Biology Discussion Group End-of-Year Symposium offers a platform for dynamic discussions and collaboration between chemists equipped with cutting-edge technologies and biologists eager to apply these tools to solve complex biological problems.
The program highlights two distinguished keynote speakers — Alanna Schepartz, PhD, from University of California, Berkeley, and Thomas Paul, PhD, from Pfizer — and a selection of junior researchers showcasing innovative work in chemical biology. Attendees will gain insights into the latest discoveries, spanning topics such as chemical probes, drug design, and molecular therapeutics, in this rapidly expanding field.